作者

Paul England, DPhil

高级专业支持律师

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Judith Krens

合伙人

Read More

Verena Bertram

授薪合伙人

Read More
作者

Paul England, DPhil

高级专业支持律师

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Judith Krens

合伙人

Read More

Verena Bertram

授薪合伙人

Read More

2019年12月19日

Synapse - December 2019

This month on Synapse

The 2020s: Boris Johnson's decade to prove his life sciences plan

Paul England discusses what the impact of the Conservative Party election victory may be for the life sciences sector.

No automatic compensation for a wrongful PI, rules the CJEU

Judith Krens and Emma Jansen explain guidance given by the Court of Justice of the European Union in case C-688/17 on the compensation parties can receive when a patent holder has enforced a preliminary injunction against them that is later revoked.

SPC manufacturing waiver (Part 2): The fairy tale of day-1 entry under the manufacturing and stockpiling waiver – a German view

Anja Lunze and Verena Bertram ask whether the new SPC manufacturing waiver offers enough to privilege the manufacture and storage of a corresponding product in the EU in the six months preceding the expiry of the SPC to achieve a day-1 entry.

AI + data = drug discovery

Paul England asks what impact we should expect to see on drug innovation from the combination of sophisticated algorithms and huge amounts of data.

Patents diary: December 2019

In this month's patents diary, Paul England describes English cases concerning jurisdiction for a patent licence dispute and the identity of the skilled person.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

酒店与休闲

Cannabis: what's new for the 6000 year old medicine?

2018年11月8日

作者 Paul England, DPhil

点击此处了解更多